3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide

C106H110F8N18O10S5 — CID 163422069

IUPAC3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide
SMILESCCn1cnc(-c2cc(S(=O)(=O)NC)ccc2Cc2cccc(C(C)(F)F)c2)c1.CNS(=O)(=O)c1ccc(Cc2ccc(C(C)(F)F)cc2)c(-c2cn(C3CC3)cn2)c1.CNS(=O)(=O)c1ccc(Cc2cccc(C(C)(F)F)c2)c(-c2cn(C)cn2)c1.CNS(=O)(=O)c1ccc(Cc2cccc(C(C)(F)F)c2)c(-c2cn(C3CC3)cn2)c1.CNS(=O)(=O)c1ccc(Nc2ccc(-c3ccccc3)cc2)c(-c2nnn(C)n2)c1
InChIInChI=1S/2C22H23F2N3O2S.C21H23F2N3O2S.C21H20N6O2S.C20H21F2N3O2S/c1-22(23,24)17-6-3-15(4-7-17)11-16-5-10-19(30(28,29)25-2)12-20(16)21-13-27(14-26-21)18-8-9-18;1-22(23,24)17-5-3-4-15(11-17)10-16-6-9-19(30(28,29)25-2)12-20(16)21-13-27(14-26-21)18-7-8-18;1-4-26-13-20(25-14-26)19-12-18(29(27,28)24-3)9-8-16(19)10-15-6-5-7-17(11-15)21(2,22)23;1-22-30(28,29)18-12-13-20(19(14-18)21-24-26-27(2)25-21)23-17-10-8-16(9-11-17)15-6-4-3-5-7-15;1-20(21,22)16-6-4-5-14(10-16)9-15-7-8-17(28(26,27)23-2)11-18(15)19-12-25(3)13-24-19/h3-7,10,12-14,18,25H,8-9,11H2,1-2H3;3-6,9,11-14,18,25H,7-8,10H2,1-2H3;5-9,11-14,24H,4,10H2,1-3H3;3-14,22-23H,1-2H3;4-8,10-13,23H,9H2,1-3H3
InChIKeyAJHGKNPMVXJRHZ-UHFFFAOYSA-N
MW2108.48 g/mol
LogP20.07
Rot. Bonds33

About 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide

3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide (PubChem CID 163422069) has the molecular formula C106H110F8N18O10S5 and a molecular weight of 2108.48 g/mol. Its IUPAC name is 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide.

Molecular Properties

Compound Name3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide
PubChem CID163422069
Molecular FormulaC106H110F8N18O10S5
Molecular Weight2108.48 g/mol
Exact Mass2106.71
IUPAC Name3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide
SMILESCCn1cnc(-c2cc(S(=O)(=O)NC)ccc2Cc2cccc(C(C)(F)F)c2)c1.CNS(=O)(=O)c1ccc(Cc2ccc(C(C)(F)F)cc2)c(-c2cn(C3CC3)cn2)c1.CNS(=O)(=O)c1ccc(Cc2cccc(C(C)(F)F)c2)c(-c2cn(C)cn2)c1.CNS(=O)(=O)c1ccc(Cc2cccc(C(C)(F)F)c2)c(-c2cn(C3CC3)cn2)c1.CNS(=O)(=O)c1ccc(Nc2ccc(-c3ccccc3)cc2)c(-c2nnn(C)n2)c1
InChIInChI=1S/2C22H23F2N3O2S.C21H23F2N3O2S.C21H20N6O2S.C20H21F2N3O2S/c1-22(23,24)17-6-3-15(4-7-17)11-16-5-10-19(30(28,29)25-2)12-20(16)21-13-27(14-26-21)18-8-9-18;1-22(23,24)17-5-3-4-15(11-17)10-16-6-9-19(30(28,29)25-2)12-20(16)21-13-27(14-26-21)18-7-8-18;1-4-26-13-20(25-14-26)19-12-18(29(27,28)24-3)9-8-16(19)10-15-6-5-7-17(11-15)21(2,22)23;1-22-30(28,29)18-12-13-20(19(14-18)21-24-26-27(2)25-21)23-17-10-8-16(9-11-17)15-6-4-3-5-7-15;1-20(21,22)16-6-4-5-14(10-16)9-15-7-8-17(28(26,27)23-2)11-18(15)19-12-25(3)13-24-19/h3-7,10,12-14,18,25H,8-9,11H2,1-2H3;3-6,9,11-14,18,25H,7-8,10H2,1-2H3;5-9,11-14,24H,4,10H2,1-3H3;3-14,22-23H,1-2H3;4-8,10-13,23H,9H2,1-3H3
InChIKeyAJHGKNPMVXJRHZ-UHFFFAOYSA-N
XLogP20.07
TPSA357.76 Ų
H-Bond Donors6
H-Bond Acceptors23
Rotatable Bonds33
Heavy Atoms147
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002108.48
LogP ≤ 520.07
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1023

Analyze 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide?
The IUPAC name of 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide (CID 163422069) is 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide.
What is the SMILES notation for 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide?
The canonical SMILES for 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide is CCn1cnc(-c2cc(S(=O)(=O)NC)ccc2Cc2cccc(C(C)(F)F)c2)c1.CNS(=O)(=O)c1ccc(Cc2ccc(C(C)(F)F)cc2)c(-c2cn(C3CC3)cn2)c1.CNS(=O)(=O)c1ccc(Cc2cccc(C(C)(F)F)c2)c(-c2cn(C)cn2)c1.CNS(=O)(=O)c1ccc(Cc2cccc(C(C)(F)F)c2)c(-c2cn(C3CC3)cn2)c1.CNS(=O)(=O)c1ccc(Nc2ccc(-c3ccccc3)cc2)c(-c2nnn(C)n2)c1.
What is the InChIKey of 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide?
The InChIKey is AJHGKNPMVXJRHZ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C22H23F2N3O2S.C21H23F2N3O2S.C21H20N6O2S.C20H21F2N3O2S/c1-22(23,24)17-6-3-15(4-7-17)11-16-5-10-19(30(28,29)25-2)12-20(16)21-13-27(14-26-21)18-8-9-18;1-22(23,24)17-5-3-4-15(11-17)10-16-6-9-19(30(28,29)25-2)12-20(16)21-13-27(14-26-21)18-7-8-18;1-4-26-13-20(25-14-26)19-12-18(29(27,28)24-3)9-8-16(19)10-15-6-5-7-17(11-15)21(2,22)23;1-22-30(28,29)18-12-13-20(19(14-18)21-24-26-27(2)25-21)23-17-10-8-16(9-11-17)15-6-4-3-5-7-15;1-20(21,22)16-6-4-5-14(10-16)9-15-7-8-17(28(26,27)23-2)11-18(15)19-12-25(3)13-24-19/h3-7,10,12-14,18,25H,8-9,11H2,1-2H3;3-6,9,11-14,18,25H,7-8,10H2,1-2H3;5-9,11-14,24H,4,10H2,1-3H3;3-14,22-23H,1-2H3;4-8,10-13,23H,9H2,1-3H3.
What are the key properties of 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide?
3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide has a molecular weight of 2108.48 g/mol, XLogP of 20.07, 33 rotatable bonds, 6 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide is sourced from PubChem (CID 163422069), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).